BD Names Bridget Bagnato Worldwide President of Peripheral Intervention
PR Newswire•04/11/2026•06:50 ET
0
Key Highlights
- ➤Bridget Bagnato appointed worldwide president of BD’s Peripheral Intervention business, effective November 16
- ➤Bagnato will lead global strategic, operational and commercial performance for Peripheral Intervention
- ➤Bagnato currently leads BD’s Specimen Management business after more than 27 years at BD
Expert Statements
Peter Menziuso, Executive vice president and president of BD’s Interventional segment
“Bridget brings deep experience across BD and a strong understanding of our customers, with a proven ability to grow businesses through innovation and operational excellence,”
Peter Menziuso, Executive vice president and president of BD’s Interventional segment
“I’m confident she will build on Peripheral Intervention’s strong foundation, advancing differentiated technologies across peripheral vascular disease, oncology, and end-stage kidney disease to address significant unmet needs and deliver greater value for customers and patients.”
BD Names Bridget Bagnato Worldwide President of Peripheral Intervention PR Newswire
FRANKLIN LAKES, N.J., Nov. 4, 2026 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced that Bridget Bagnato has been appointed worldwide president of its Peripheral Intervention business unit, effective November 16.
Get started
Create a free account to read the full story.